NeuroOne (NMTC) CAO Emily Johns Receives 12,500-Share Award

What Happened
Emily J. Johns, Chief Administrative Officer of NeuroOne Medical Technologies Corp (NMTC), was awarded 12,500 derivative shares on 2026-08-28. The award was granted at $0.00 (no cash exchanged) and is reported as an acquisition (award/grant). This is a compensation award (likely RSUs or similar) rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-08-28; Grant type: Award/Grant (code A); Price reported: $0.00.
• Shares granted: 12,500 derivative shares (no immediate cash value reported in the filing).
• Vesting: 25% vest on August 28, 2027; the remaining 75% vest in 12 equal quarterly installments (i.e., over the next 3 years).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timeliness: Filing date is 2026-08-28 (same day as the transaction); no late filing indicated in the provided data.
• Footnote: Vesting schedule as noted above (25% one-year cliff, then quarterly vesting for the remainder).

Context
This was a compensation grant (derivative award) rather than a market buy or sale. Awards like RSUs do not require cash up front and become economically valuable only as they vest; they are common as employee retention and incentive compensation. The filing does not state a cash value — the eventual dollar value will depend on NMTC’s share price when portions of the award vest.